ArticleScience progress
Endobronchial malakoplakia in a young woman with rheumatoid arthritis: A case report.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malakoplakia is a rare inflammatory condition characterized by the accumulation of granulomatous masses due to the incomplete destruction of infectious pathogens by monocytes and macrophages. While it commonly affects the genitourinary tract, pulmonary malakoplakia is infrequent and often associated with immunocompromised states. We present the case of a woman in her early 40s with rheumatoid arthritis who developed localized pulmonary malakoplakia in the airway. Initially presenting with constitutional symptoms and respiratory distress, she underwent a diagnostic evaluation revealing an endobronchial mass with neoplastic characteristics. Histopathological examination confirmed the presence of Michaelis-Gutmann bodies, pathognomonic for malakoplakia. Despite initial improvement postresection, the patient experienced disease recurrence 1 year later. Pulmonary malakoplakia, although rare, poses diagnostic challenges due to its resemblance to malignant lesions. Treatment typically involves antibiotic therapy, low-dose steroids, and localized resections. Differential diagnoses include primary or secondary malignancies, necessitating histopathological evaluation for accurate diagnosis. Malakoplakia should be considered in immunocompromised individuals presenting with pulmonary nodules or masses, especially without malignancy risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.